DE602004022205D1 - Pharmazeutische zusammensetzung für die verzögerte freisetzung von hydralazin und ihre verwendung als unterstützung zur krebstherapie - Google Patents
Pharmazeutische zusammensetzung für die verzögerte freisetzung von hydralazin und ihre verwendung als unterstützung zur krebstherapieInfo
- Publication number
- DE602004022205D1 DE602004022205D1 DE602004022205T DE602004022205T DE602004022205D1 DE 602004022205 D1 DE602004022205 D1 DE 602004022205D1 DE 602004022205 T DE602004022205 T DE 602004022205T DE 602004022205 T DE602004022205 T DE 602004022205T DE 602004022205 D1 DE602004022205 D1 DE 602004022205D1
- Authority
- DE
- Germany
- Prior art keywords
- hydralazine
- support
- pharmaceutical composition
- cancer therapy
- delayed release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- RPTUSVTUFVMDQK-UHFFFAOYSA-N Hidralazin Chemical compound C1=CC=C2C(NN)=NN=CC2=C1 RPTUSVTUFVMDQK-UHFFFAOYSA-N 0.000 title 2
- 230000003111 delayed effect Effects 0.000 title 1
- 229960002474 hydralazine Drugs 0.000 title 1
- 238000011275 oncology therapy Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/MX2004/000064 WO2006028362A1 (es) | 2004-09-09 | 2004-09-09 | Composición farmacéutica de liberación prolongada de hidralazina y su uso como apoyo para el tratamiento del cáncer |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004022205D1 true DE602004022205D1 (de) | 2009-09-03 |
Family
ID=36036613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004022205T Expired - Lifetime DE602004022205D1 (de) | 2004-09-09 | 2004-09-09 | Pharmazeutische zusammensetzung für die verzögerte freisetzung von hydralazin und ihre verwendung als unterstützung zur krebstherapie |
Country Status (17)
Country | Link |
---|---|
US (1) | US7820200B2 (de) |
EP (1) | EP1803447B1 (de) |
JP (1) | JP4814885B2 (de) |
CN (1) | CN101039661A (de) |
BR (1) | BRPI0419032B8 (de) |
CA (1) | CA2579220C (de) |
CR (1) | CR9035A (de) |
CY (1) | CY1110508T1 (de) |
DE (1) | DE602004022205D1 (de) |
DK (1) | DK1803447T3 (de) |
ES (1) | ES2330227T3 (de) |
MX (1) | MX2007002871A (de) |
NZ (1) | NZ554360A (de) |
PL (1) | PL1803447T3 (de) |
PT (1) | PT1803447E (de) |
SI (1) | SI1803447T1 (de) |
WO (1) | WO2006028362A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR101476A1 (es) | 2014-08-07 | 2016-12-21 | Acerta Pharma Bv | Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK150008C (da) | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
US4521402A (en) * | 1983-01-03 | 1985-06-04 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of hydrazine |
US4461759A (en) * | 1983-01-03 | 1984-07-24 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of veropamil |
IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
GB8624213D0 (en) * | 1986-10-09 | 1986-11-12 | Sandoz Canada Inc | Sustained release pharmaceutical compositions |
EP1611881A1 (de) * | 1999-03-31 | 2006-01-04 | Janssen Pharmaceutica N.V. | Vorgelatinierte Stärke in einer Formulierung mit gesteuerter Freigabe |
US20030091630A1 (en) * | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
US20050226926A1 (en) * | 2002-07-25 | 2005-10-13 | Pfizer Inc | Sustained-release tablet composition of pramipexole |
AU2003301654A1 (en) * | 2002-10-22 | 2004-05-13 | Dainippon Pharmaceutical Co., Ltd. | Stabilized composition |
-
2004
- 2004-09-09 ES ES04774809T patent/ES2330227T3/es not_active Expired - Lifetime
- 2004-09-09 NZ NZ554360A patent/NZ554360A/en not_active IP Right Cessation
- 2004-09-09 DE DE602004022205T patent/DE602004022205D1/de not_active Expired - Lifetime
- 2004-09-09 US US11/575,016 patent/US7820200B2/en active Active
- 2004-09-09 DK DK04774809T patent/DK1803447T3/da active
- 2004-09-09 CA CA2579220A patent/CA2579220C/en not_active Expired - Lifetime
- 2004-09-09 CN CNA2004800439530A patent/CN101039661A/zh active Pending
- 2004-09-09 SI SI200431198T patent/SI1803447T1/sl unknown
- 2004-09-09 PT PT04774809T patent/PT1803447E/pt unknown
- 2004-09-09 BR BRPI0419032A patent/BRPI0419032B8/pt not_active IP Right Cessation
- 2004-09-09 EP EP04774809A patent/EP1803447B1/de not_active Expired - Lifetime
- 2004-09-09 WO PCT/MX2004/000064 patent/WO2006028362A1/es active Application Filing
- 2004-09-09 JP JP2007531093A patent/JP4814885B2/ja not_active Expired - Lifetime
- 2004-09-09 PL PL04774809T patent/PL1803447T3/pl unknown
-
2007
- 2007-03-09 MX MX2007002871A patent/MX2007002871A/es active IP Right Grant
- 2007-04-09 CR CR9035A patent/CR9035A/es not_active Application Discontinuation
-
2009
- 2009-10-13 CY CY20091101053T patent/CY1110508T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
MX2007002871A (es) | 2007-04-23 |
JP2008512450A (ja) | 2008-04-24 |
BRPI0419032B8 (pt) | 2021-05-25 |
CR9035A (es) | 2009-03-27 |
SI1803447T1 (sl) | 2010-01-29 |
PT1803447E (pt) | 2009-08-14 |
US20090042889A1 (en) | 2009-02-12 |
CA2579220A1 (en) | 2006-03-16 |
CA2579220C (en) | 2013-01-08 |
CY1110508T1 (el) | 2015-04-29 |
WO2006028362A1 (es) | 2006-03-16 |
DK1803447T3 (da) | 2009-10-12 |
ES2330227T3 (es) | 2009-12-07 |
CN101039661A (zh) | 2007-09-19 |
BRPI0419032B1 (pt) | 2019-02-05 |
BRPI0419032A (pt) | 2007-12-11 |
JP4814885B2 (ja) | 2011-11-16 |
EP1803447B1 (de) | 2009-07-22 |
US7820200B2 (en) | 2010-10-26 |
NZ554360A (en) | 2009-11-27 |
PL1803447T3 (pl) | 2010-05-31 |
EP1803447A1 (de) | 2007-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL183583A (en) | Quinazoline History and Pharmaceuticals Containing Them and Methods of Manufacturing | |
ZA200711085B (en) | Processes for the manufacture of rosuvastatin and intermediates | |
HK1077583A1 (en) | Cudr as biomarker for cancer progression and therapeutic response | |
IL180657A0 (en) | Arylidenes for the treatment of estrogen related receptor-alpha mediated diseases | |
IL188712A0 (en) | Novel anti-igf-ir antibodies and uses thereof | |
IL181025A0 (en) | Novel anti-igf-ir antibodies and uses thereof | |
ATE502960T1 (de) | Lingo bindende moleküle und pharmazeutische verwendung davon | |
IL186071A0 (en) | Antibodies against ccr5 and uses thereof | |
ATE428710T1 (de) | Substituierte phenylaminothiazole und ihre verwendung | |
TWI367932B (en) | Fluorescence material and manufacture thereof | |
PT2343320T (pt) | Anticorpos anti-gitr e as suas utilizações | |
ATE493396T1 (de) | Neue indazolcarboxamide und ihre verwendung | |
IL181608A0 (en) | Cancer combination therapy comprising azd2171 and imatinib | |
IL190522A (en) | A medicinal product containing hydrocarbon testosterone gel and use of testosterone to make the preparation | |
DE602006019611D1 (de) | Neues künstliches basenpaar und verwendung davon | |
EP1978034A4 (de) | Antiperiostin-antikörper und pharmazeutische zusammensetzung zur prävention oder behandlung von mit periostin in zusammenhang stehenden krankheiten, die diese enthält | |
EP1937816A4 (de) | Marker zur krebsdiagnose und verwendung davon | |
HK1080397A1 (en) | An acrylic acid-based binder composition and the pharmaceutical composition and transdermal therapeutic system thereof | |
GB0516069D0 (en) | Pharmaceutical and use thereof | |
DE602007005372D1 (de) | Zweischichtige tablette zur verhinderung von kardiovaskulären ereignissen | |
DE602006004713D1 (de) | Trifluormethylbenzamidderivate und therapeutische verwendungen dafür | |
DE602006009296D1 (de) | Oligopeptide und ihre verwendung | |
EP1951681A4 (de) | Neue 2-aminopyrimidinderivate und deren verwendung | |
WO2006026027A8 (en) | Markers of alterations in the y chromosome and uses therefor | |
DE602006013009D1 (de) | Pharmazeutische zusammensetzung von mahanin zur behandlung von prostatakrebs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |